2,5-Dimethoxy-4-(2-fluoroethyl)amphetamine (DOEF; also known as dimethoxyfluoroethylamphetamine) is a lesser-known
psychedelic drug
Psychedelics are a subclass of hallucinogenic drugs whose primary effect is to trigger non-ordinary states of consciousness (known as psychedelic experiences or "trips").Pollan, Michael (2018). ''How to Change Your Mind: What the New Science o ...
and member of the
DOx class. DOEF was first synthesized by
Alexander Shulgin
Alexander Theodore "Sasha" Shulgin (June 17, 1925 – June 2, 2014) was an American medicinal chemist, biochemist, organic chemist, pharmacologist, psychopharmacologist, and author. He is credited with introducing 3,4-methylenedioxymethamph ...
. In his book ''
PiHKAL'', the dosage range is listed as 2–3.5 mg, and the duration is listed as 12–16 hours.
DOEF Entry in ''PiHKAL''
/ref> Very little data exists about the pharmacological properties, metabolism, and toxicity of DOEF.
See also
* DOET
* DOPF
DOPF is a designer drug from the substituted amphetamine family. It was first synthesised by Alexander Shulgin and David Nichols in 1989 but was never published at the time, and was finally disclosed in Daniel Trachsel's review of the field in ...
* DOTFM
References
Substituted amphetamines
Fluoroethyl compounds
{{Psychoactive-stub